Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
J GranchiDepartment of Neurology, Mitchell Center for Neurodegenerative Diseases, Graduate School of Biomedical Sciences, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
B SalamehDepartment of Neurology, Mitchell Center for Neurodegenerative Diseases, Graduate School of Biomedical Sciences, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
B MillerDepartment of Neurology, Mitchell Center for Neurodegenerative Diseases, Graduate School of Biomedical Sciences, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
P ScadutoDepartment of Neurology, Mitchell Center for Neurodegenerative Diseases, Graduate School of Biomedical Sciences, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
W K RussellDepartment of Biochemistry & Molecular Biology, UTMB Mass Spectrometry Proteomics Center, Graduate School of Biomedical Sciences, University of Texas Medical Branch at Galveston, Galveston, TX, USA.ORCID http://orcid.org/0000-0003-1931-4555
T D MeyerLouis A. Faillace, MD Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID http://orcid.org/0000-0003-4236-7778
A L TeixeiraLouis A. Faillace, MD Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID http://orcid.org/0000-0002-9621-5422
G R FriesLouis A. Faillace, MD Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID http://orcid.org/0000-0002-5468-2612
L StertzLouis A. Faillace, MD Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID http://orcid.org/0000-0002-1426-6796
C Walss-BassLouis A. Faillace, MD Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.
A LimonDepartment of Neurology, Mitchell Center for Neurodegenerative Diseases, Graduate School of Biomedical Sciences, University of Texas Medical Branch at Galveston, Galveston, TX, USA. aglimonr@utmb.edu.ORCID http://orcid.org/0000-0002-6613-770X
Funding
Tau oligomer conformers and synaptic vulnerability/resilience in AD and related disordersR01AG073133 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LIMON, AGENOR, TAGLIALATELA, GIULIO · 2021 to 2025
$3.8M
Gene-environment interactions in COCCaINE Use Disorder: Collaborative Case-Control Initiative in Coccaine AddictionR01DA044859 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI GRASSI-OLIVEIRA, RODRIGO, SCHMITZ, JOY MARIE · 2017 to 2021
$2.8M
Mechanisms of Synaptic Protection in Cognitive Resilence to Alzheimer's Disease NeuropathologyR01AG070255 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LIMON, AGENOR · 2021 to 2025
$2.2M
Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RP190682Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RP250644NIA NIH HHS R01 AG070255NIA NIH HHS R01 AG073133NIDA NIH HHS R01 DA044859U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) AG070255U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) AG073133
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Multi-omics and electrophysiological examination of GABA · full record | OpenQuestion